Tlr9tm2.1Gbrt
Targeted Allele Detail
|
Symbol: |
Tlr9tm2.1Gbrt |
Name: |
toll-like receptor 9; targeted mutation 2.1, Gregory M Barton |
MGI ID: |
MGI:6459287 |
Synonyms: |
TLR9fsTM |
Gene: |
Tlr9 Location: Chr9:106099797-106104075 bp, + strand Genetic Position: Chr9, 57.46 cM
|
Alliance: |
Tlr9tm2.1Gbrt page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:287989
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
|
Allele Type: |
|
Targeted (Conditional ready, Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The targeting vector contains a loxP-flanked STOP cassette upstream of exon 2, an internal ribosome entry site (IRES) fused to a green fluorescent protein (GFP) sequence inserted downstream of exon 2, and a mutation was introduced in exon 2, in the transmembrane domain. The construct also contains an FRT-flanked neomycin resistance (neo) cassette. Flp-mediated recombination removed the FRT-flanked neo cassette.
(J:287989)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Tlr9 Mutation: |
65 strains or lines available
|
|
Original: |
J:287989 Stanbery AG, et al., Dysregulation of TLR9 in neonates leads to fatal inflammatory disease driven by IFN-gamma. Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3074-3082 |
All: |
1 reference(s) |
|